• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

围生期预防支气管肺发育不良。

Perinatal prevention of bronchopulmonary dysplasia.

机构信息

Division of Asthma, Allergy and Lung Biology, School of Medicine, King's College London, London, UK.

出版信息

J Perinat Med. 2013 Jan;41(1):119-26. doi: 10.1515/jpm-2012-0084.

DOI:10.1515/jpm-2012-0084
PMID:23096098
Abstract

Bronchopulmonary dysplasia (BPD), defined as oxygen dependency for at least 28 days after birth, is a common adverse outcome of very premature birth. Affected children require frequent readmissions to hospital in the fi rst 2 years, and although lung growth and remodelling results in progressive improvement in lung function, airflow abnormalities may remain. Indeed, the most severely affected experience troublesome respiratory symptoms as adolescents and young adults. As a consequence, many potential preventative strategies have been investigated, and some have resulted in a reduction in BPD but with a negative risk/benefit ratio, for example, postnatal corticosteroids. Others therapies, namely antenatal corticosteroids and postnatal surfactant, have resulted in significant benefits to infants, including reductions in respiratory distress syndrome, necrotising enterocolitis, intraventricular haemorrhage and neonatal death, but have not impacted favourably on the incidence of BPD, perhaps due to the increased survival of very immature infants. In one major trial, it has been shown that BPD can be reduced without adverse effects by caffeine administration. Avoidance of high oxygen concentrations at resuscitation is also a promising approach to reduce BPD.

摘要

支气管肺发育不良(BPD)定义为出生后至少需要氧疗 28 天,是极早产儿常见的不良结局。受影响的儿童在出生后 2 年内需要频繁住院,尽管肺生长和重塑导致肺功能逐渐改善,但气流异常仍可能存在。事实上,最严重的患者在青少年和年轻成人时期会出现麻烦的呼吸道症状。因此,已经研究了许多潜在的预防策略,但有些策略虽然降低了 BPD 的发生率,但风险/效益比为负,例如,产后皮质类固醇。其他治疗方法,即产前皮质类固醇和产后表面活性剂,使婴儿显著受益,包括降低呼吸窘迫综合征、坏死性小肠结肠炎、脑室出血和新生儿死亡,但对 BPD 的发生率没有产生有利影响,这可能是由于极不成熟婴儿的存活率增加。在一项大型试验中,已经表明通过给予咖啡因可以减少 BPD 而没有不良反应。避免在复苏时使用高氧浓度也是一种有前途的方法,可以降低 BPD 的发生率。

相似文献

1
Perinatal prevention of bronchopulmonary dysplasia.围生期预防支气管肺发育不良。
J Perinat Med. 2013 Jan;41(1):119-26. doi: 10.1515/jpm-2012-0084.
2
A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.一项关于卢西纳可坦与猪肺磷脂在极早早产儿呼吸窘迫综合征高危人群中进行的多中心、随机、对照试验。
Pediatrics. 2005 Apr;115(4):1030-8. doi: 10.1542/peds.2004-2231.
3
A comprehensive approach to the prevention of bronchopulmonary dysplasia.全面防治支气管肺发育不良。
Pediatr Pulmonol. 2011 Dec;46(12):1153-65. doi: 10.1002/ppul.21508. Epub 2011 Aug 3.
4
A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants.地塞米松预防接受表面活性剂治疗婴儿支气管肺发育不良的对照试验。
Pediatrics. 1996 Aug;98(2 Pt 1):204-10.
5
[Bronchopulmonary dysplasia].支气管肺发育不良
Rev Mal Respir. 1996 Jul;13(3):243-9.
6
Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis.布地奈德-表面活性剂气管内给药预防极低出生体重儿支气管肺发育不良:一项系统评价和荟萃分析
Pediatr Pulmonol. 2017 Jul;52(7):968-975. doi: 10.1002/ppul.23680. Epub 2017 Feb 6.
7
[From classic to new bronchopulmonary dysplasia].[从经典型到新型支气管肺发育不良]
Ned Tijdschr Geneeskd. 2010;154:A1024.
8
Bronchopulmonary dysplasia.支气管肺发育不良
Respir Care. 2009 Sep;54(9):1252-62.
9
Combined effects of antenatal corticosteroids and surfactant supplementation on the outcome of very low birth weight infants.产前使用皮质类固醇激素与补充表面活性物质对极低出生体重儿结局的联合影响。
J Perinatol. 1996 Nov-Dec;16(6):422-8; quiz 429-30.
10
The evolution of neonatal respiratory distress syndrome into chronic lung disease.新生儿呼吸窘迫综合征向慢性肺病的演变。
Eur Respir J Suppl. 1989 Mar;3:33s-37s.

引用本文的文献

1
Early Diagnosis of Bronchopulmonary Dysplasia with E-Nose: A Pilot Study in Preterm Infants.用电子鼻早期诊断支气管肺发育不良:一项对早产儿的初步研究。
Sensors (Basel). 2024 Sep 28;24(19):6282. doi: 10.3390/s24196282.
2
Evaluation of Short-Term Outcomes of Preterm Infants in 2 Periods: Vermont Oxford Network Results of a Developing Country's Single- Center Level IIIC Neonatal Intensive Care Unit Experience.两个时期早产儿短期结局的评估:佛蒙特牛津网络关于一个发展中国家单中心IIIC级新生儿重症监护病房经验的结果
Turk Arch Pediatr. 2023 Mar;58(2):159-167. doi: 10.5152/TurkArchPediatr.2023.22253.
3
Composition and origin of lung fluid proteome in premature infants and relationship to respiratory outcome.
早产儿肺液蛋白质组的组成和来源及其与呼吸结局的关系。
PLoS One. 2020 Dec 10;15(12):e0243168. doi: 10.1371/journal.pone.0243168. eCollection 2020.
4
Prevention, Reduction and Repair of Brain Injury of the Preterm Infant.早产儿脑损伤的预防、减轻及修复
Front Physiol. 2019 Mar 20;10:181. doi: 10.3389/fphys.2019.00181. eCollection 2019.
5
Ancestry and genetic associations with bronchopulmonary dysplasia in preterm infants.早产儿支气管肺发育不良的遗传相关性和遗传关联。
Am J Physiol Lung Cell Mol Physiol. 2018 Nov 1;315(5):L858-L869. doi: 10.1152/ajplung.00073.2018. Epub 2018 Aug 16.
6
Anti-inflammatory effect of caffeine is associated with improved lung function after lipopolysaccharide-induced amnionitis.咖啡因的抗炎作用与脂多糖诱导的羊膜炎后肺功能改善有关。
Neonatology. 2014;106(3):235-40. doi: 10.1159/000363217. Epub 2014 Jul 5.
7
Reducing the incidence of chronic lung disease in very premature infants with aminophylline.使用氨茶碱降低极早产儿慢性肺病的发病率。
Int J Prev Med. 2014 May;5(5):569-76.
8
Chronic lung disease in the preterm infant. Lessons learned from animal models.早产儿慢性肺病。动物模型中获得的经验教训。
Am J Respir Cell Mol Biol. 2014 Feb;50(2):233-45. doi: 10.1165/rcmb.2013-0014TR.